Related Experiment Video
Updated: Jun 24, 2025
05:17
BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
1.2K
GABAergic implications in anxiety and related disorders
Indu Arora1, Pankaj Mal1, Poonam Arora1
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Biochemical and Biophysical Research Communications
|June 12, 2024
Summary
Anxiety disorders involve brain circuit imbalances affecting emotional responses. Reduced GABAergic activity and altered GABAA receptors in the amygdala are linked to pathological anxiety.
Area of Science:
- Neuroscience
- Psychiatry
- Molecular Biology
Background:
- Anxiety disorders stem from dysregulated brain circuits modulating emotional responses to threats.
- Key circuits involve amygdala activity and prefrontal cortex regulatory control.
- GABAergic system dysfunction is implicated in anxiety and depression.
Purpose of the Study:
- To review the neuroanatomical and neural circuit basis of anxiety disorders.
- To explore the role of GABAergic signaling and GABAA receptors in anxiety.
- To identify potential molecular targets for anxiolytic treatments.
Main Methods:
- Literature search of scientific databases (PubMed, ScienceDirect, Web of Science, Google Scholar).
- Keywords included "anxiety", "stress", "neuroanatomy", and "neural circuits".
- Analysis of evidence from human functional imaging and animal studies.
Main Results:
- Reduced GABAergic activity observed in anxiety disorders and depression.
- Lower GABA levels in cortical regions of depressed individuals.
- Decreased GABAA/B receptor expression in animals induced anxiety-like behaviors.
- GABAergic interneurons in the amygdala modulate anxiety responses.
- GABAA receptor allosteric sites are targets for benzodiazepines and barbiturates.
Conclusions:
- Alterations in GABAergic signaling and GABAA receptor composition contribute to diminished neuronal inhibition in pathological anxiety.
- Dysregulation of GABAA receptor allosteric sites may underlie anxiety disorders.
- Understanding these mechanisms can inform the development of novel anxiolytic therapies.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
17.4K
14:40Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
Published on: October 27, 2020
18.2K
Related Concept Videos
01:30Generalized Anxiety Disorder
107
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
107
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
679
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
679
01:26Anxiolytic Drugs: Overview
272
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
272
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
01:18Anxiety: Overview
265
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
265
01:14CNS Depressants: Barbiturates and Benzodiazepines
250
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
250